Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/18/2865819/15114/en/Lumos-Pharma-Announces-Abstracts-Accepted-for-Presentation-at-Upcoming-Medical-Meetings.html
https://www.globenewswire.com/news-release/2024/03/20/2849307/15114/en/Lumos-Pharma-Announces-that-the-USPTO-Has-Granted-Patent-Protection-for-Novel-Formulation-of-LUM-201-Extending-Exclusivity-to-2042.html
https://www.globenewswire.com//news-release/2024/03/07/2842720/15114/en/Lumos-Pharma-Reports-Full-Year-2023-Financial-Results-and-Provides-Clinical-Development-Update.html
https://www.globenewswire.com//news-release/2024/02/26/2835146/15114/en/Lumos-Pharma-to-Report-Full-Year-2023-Financial-Results-and-Host-Conference-Call-on-March-7-2024.html
https://www.globenewswire.com//news-release/2024/02/05/2823843/15114/en/Lumos-Pharma-to-Participate-in-Oppenheimer-s-34th-Annual-Healthcare-Life-Sciences-Conference.html
https://www.globenewswire.com//news-release/2024/01/04/2804321/15114/en/Lumos-Pharma-Promotes-Pisit-Duke-Pitukcheewanont-MD-to-Chief-Medical-Officer.html
https://www.globenewswire.com//news-release/2023/11/21/2784430/15114/en/Lumos-Pharma-to-Host-Virtual-Key-Opinion-Leader-Webinar-to-Discuss-Phase-2-OraGrowtH-Trial-Data-and-Treatment-Potential-of-Oral-LUM-201-for-Pediatric-Growth-Hormone-Deficiency.html
https://www.globenewswire.com/news-release/2023/11/20/2783597/15114/en/Lumos-Pharma-Announces-Participation-in-the-Piper-Sandler-35th-Annual-Healthcare-Conference-in-November.html
https://www.fiercebiotech.com/biotech/lumos-stock-rockets-phase-2-results-bring-first-oral-growth-hormone-drug-one-step-closer
https://www.globenewswire.com//news-release/2023/11/07/2775696/15114/en/Lumos-Pharma-Reports-Third-Quarter-2023-Financial-Results-and-Clinical-Development-Updates.html